IQGAP2 acts as an independent prognostic factor and is related to immunosuppression in DLBCL
Abstract Background Almost one-third of patients with diffuse large B-cell lymphoma (DLBCL) cannot be cured with initial therapy and will eventually succumb to the disease. Further elaboration of prognostic markers of DLBCL will provide therapeutic targets. IQ motif-containing GTPase activating prot...
Main Authors: | Tianjiao Tang, Jing Wang, Lidan Zhang, Ying Cheng, Laura Saleh, Yanni Gu, Hongbin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08086-y |
Similar Items
-
The Tumor Microenvironment of DLBCL in the Computational Era
by: Giuseppina Opinto, et al.
Published: (2020-03-01) -
The interplay between IQGAP1 and small GTPases in cancer metastasis
by: Xiafeng Peng, et al.
Published: (2021-03-01) -
Enhancement of Migration and Invasion of Gastric Cancer Cells by IQGAP3
by: Natini Jinawath, et al.
Published: (2020-08-01) -
A Labile Pool of IQGAP1 Disassembles Endothelial Adherens Junctions
by: Wen Tan, et al.
Published: (2013-06-01) -
IQGAP3 Overexpression Correlates With Poor Prognosis and Radiation Therapy Resistance in Breast Cancer
by: Xin Hua, et al.
Published: (2021-01-01)